Machine learning-based cell death marker for predicting prognosis and identifying tumor immune microenvironment in prostate cancer
Authors:
Open Access
- 6 September 2024
- Vol. 10 (18) , e37554
Abstract
No abstract availableKeywords
Funding Information
- Hangzhou Science and Technology Bureau
- Science and Technology Program of Zhejiang Province (2024ZL685)
- Science and Technology Program of Zhejiang Province (2024ZR133)
This publication has 55 references indexed in Scilit:
- Plk1 Inhibition Enhances the Efficacy of Androgen Signaling Blockade in Castration-Resistant Prostate CancerCancer Research, 2014
- Increased Survival with Enzalutamide in Prostate Cancer after ChemotherapyNew England Journal of Medicine, 2012
- Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosisOncogene, 2012
- Imatinib causes epigenetic alterations of PTEN gene via upregulation of DNA methyltransferases and polycomb group proteinsBlood Cancer Journal, 2011
- CCI-779 Inhibits Cell-Cycle G2–M Progression and Invasion of Castration-Resistant Prostate Cancer via Attenuation of UBE2C Transcription and mRNA StabilityCancer Research, 2011
- Phospho‐MED1‐enhanced UBE2C locus looping drives castration‐resistant prostate cancer growthThe EMBO Journal, 2011
- Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein.2003
- Candidate tumor suppressor, HCCS‐1, is downregulated in human cancers and induces apoptosis in cervical cancerInternational Journal of Cancer, 2001